AuroLase
Phase 3- Indications
- Prostate cancer
Company intelligence / Profile preview
Nanospectra Biosciences
Houston, Texas, United Statesnanospectra.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 3
01
Overview
Nanospectra Biosciences has developed a proprietary ultra-focal nanomedicine platform using gold nanoshells activated by laser light to selectively ablate tumor tissue while sparing healthy tissue. Their lead program, AuroLase Therapy, has shown promising safety and efficacy results in initial human trials for prostate cancer. The company also has an exclusive commercialization partnership for veterinary oncology applications.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Nanoparticle (specifically gold nanoshells)Device (laser-based ablation system)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
LiteCure LLC / Enovis (exclusive commercialization partner for veterinary medicine applications of nanoshell technology)
Beyond the preview
Go deeper on Nanospectra Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanospectra Biosciences.